⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1929701 | 0.93 | — | — | |
| SCHEMBL9035339 | 0.90 | — | — | |
| SCHEMBL251107 | 0.90 | — | — | |
| SCHEMBL398209 | 0.90 | — | — | |
| SCHEMBL598108 | 0.86 | — | — | |
| SCHEMBL11053845 | 0.77 | ALDH1A1 (0.46) | — | |
| SCHEMBL4555494 | 0.77 | — | — | |
| SCHEMBL3300189 | 0.73 | — | — | |
| SCHEMBL4556780 | 0.73 | — | — | |
| SCHEMBL3398837 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104496901-B | The manufacture method of anthranilamide compound | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2016-05-25 | — | — | CN | claimed |
| EP-2093223-B1 | PROCESS AND INTERMEDIATES FOR PRODUCTION OF AN ANTHRANILAMIDE COMPOUND | ISHIHARA SANGYO KAISHA (JP) | 2013-08-21 | — | — | EP | claimed |
| CN-103204811-A | Process For Production Of Anthranilamide Compound | ISHIHARA SANGYO KAISHA | 2013-07-17 | — | — | CN | claimed |
| CN-101558056-B | Process for producing anthranilamide compound | ISHIHARA SANGYO KAISHA | 2013-05-01 | — | — | CN | claimed |
| US-8115006-B2 | Process for producing anthranilamide compound | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2012-02-14 | — | — | US | claimed |
| US-20100063293-A1 | PROCESS FOR PRODUCING ANTHRANILAMIDE COMPOUND | ISHIHARA SANGYO KAISHA ,LTD. (JP) | 2010-03-11 | — | — | US | claimed |
| CN-101558056-A | Process for producing anthranilamide compound | ISHIHARA SANGYO KAISHA (JP) | 2009-10-14 | — | — | CN | claimed |
| EP-2093223-A1 | PROCESS FOR PRODUCTION OF ANTHRANILAMIDE COMPOUND | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2009-08-26 | — | — | EP | claimed |
| CN-101356187-A | Oxidation process for the preparation of n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and re | SCHERING CORP (US) | 2009-01-28 | — | — | CN | claimed |
| CN-1902216-A | Depeptidized inhibitor of hepatitis C virus NS3 protease | SCHERING CORP (US) | 2007-01-24 | — | — | CN | claimed |
| EP-0773930-A1 | AROMATIC AMINO ETHERS AS PAIN RELIEVING AGENTS | ZENECA LIMITED (GB) | 1997-05-21 | — | — | EP | claimed |
| CN-109415589-A | Film forms the manufacturing method with composition and laminated body | 富士胶片株式会社 | 2019-03-01 | — | — | CN | disclosed |
| EP-3442951-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2019-02-20 | — | — | EP | disclosed |
| WO-2017178245-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2017-10-19 | — | — | WO | disclosed |
| CN-104496901-B | The manufacture method of anthranilamide compound | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2016-05-25 | — | — | CN | disclosed |
| CN-1490368-A | Hardening resin composition and protective film | 住友化学工业株式会社 | 2004-04-21 | — | — | CN | disclosed |
| EP-0828484-A1 | USE OF ARYL SUBSTITUTED CYCLOBUTYL ALKYL AMINES FOR THE TREATMENT OF OBESITY | Knoll AG (DE) | 1998-03-18 | — | — | EP | disclosed |
| EP-0773930-A1 | AROMATIC AMINO ETHERS AS PAIN RELIEVING AGENTS | ZENECA LIMITED (GB) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996038134-A1 | USE OF ARYL SUBSTITUTED CYCLOBUTYL ALKYL AMINES FOR THE TREATMENT OF OBESITY | KNOLL AG (DE) | 1996-12-05 | — | — | WO | disclosed |
| EP-0733033-A1 | PHARMACEUTICALLY ACTIVE SUBSTITUTED AROMATIC COMPOUNDS | ZENECA LIMITED (GB) | 1996-09-25 | — | — | EP | disclosed |